Caribou Historical Financial Ratios

CRBU Stock

USD 0.99 0.11 12.50%

Caribou Biosciences is presently reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.54 or Days Sales Outstanding of 72.62 will help investors to properly organize and evaluate Caribou Biosciences financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.

About Caribou Financial Ratios Analysis

Caribou BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Caribou Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Caribou financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Caribou Biosciences history.

Caribou Biosciences Financial Ratios Chart

At this time, Caribou Biosciences' Capex Per Share is comparatively stable compared to the past year.

Price To Sales Ratio Days Sales Outstanding Ev To Sales Payables Turnover

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Caribou Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Caribou Biosciences sales, a figure that is much harder to manipulate than other Caribou Biosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Most ratios from Caribou Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Caribou Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.At this time, Caribou Biosciences' Capex Per Share is comparatively stable compared to the past year.

	2022	2023	2024	2025 (projected)
Interest Debt Per Share	0.46	0.37	0.29	0.15
Revenue Per Share	0.23	0.47	0.11	0.17

Interest Debt Per Share Revenue Per Share

Caribou Biosciences fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.92	0.89	-0.74	0.76	0.9	-0.67	0.92	1.0	0.92	0.05	0.71	0.96	0.8	-0.67	-0.8	-0.65	-0.93	-0.3	0.64	-0.94	-0.09	0.78	-0.85	-0.94	-0.98
Ptb Ratio	0.92		0.72	-0.69	0.55	0.68	-0.65	1.0	0.93	0.69	0.26	0.48	0.81	0.76	-0.46	-0.65	-0.64	-0.71	-0.58	0.64	-0.73	-0.29	0.88	-0.99	-0.74	-0.88
Days Sales Outstanding	0.89	0.72		-0.43	0.76	0.89	-0.43	0.72	0.85	0.9	0.19	0.51	0.8	0.48	-0.84	-0.62	-0.32	-0.91	-0.29	0.43	-0.9	0.35	0.43	-0.66	-0.87	-0.81
Book Value Per Share	-0.74	-0.69	-0.43		-0.37	-0.61	0.89	-0.69	-0.78	-0.64	0.51	-0.87	-0.8	-0.94	0.23	0.82	0.99	0.66	-0.13	-0.88	0.69	0.61	-0.88	0.63	0.75	0.83
Free Cash Flow Yield	0.76	0.55	0.76	-0.37		0.87	-0.15	0.55	0.73	0.84	0.04	0.64	0.81	0.59	-0.78	-0.63	-0.28	-0.85	-0.05	0.09	-0.84	0.14	0.39	-0.44	-0.83	-0.76
Operating Cash Flow Per Share	0.9	0.68	0.89	-0.61	0.87		-0.56	0.68	0.88	1.0	-0.11	0.78	0.94	0.68	-0.7	-0.82	-0.5	-0.99	-0.01	0.42	-0.99	0.15	0.51	-0.57	-0.98	-0.9
Capex To Depreciation	-0.67	-0.65	-0.43	0.89	-0.15	-0.56		-0.65	-0.7	-0.6	0.4	-0.68	-0.7	-0.73	0.05	0.73	0.87	0.59	-0.03	-0.87	0.61	0.42	-0.74	0.62	0.65	0.72
Pb Ratio	0.92	1.0	0.72	-0.69	0.55	0.68	-0.65		0.93	0.69	0.26	0.48	0.81	0.76	-0.46	-0.65	-0.64	-0.71	-0.58	0.64	-0.73	-0.29	0.88	-0.99	-0.74	-0.88
Ev To Sales	1.0	0.93	0.85	-0.78	0.73	0.88	-0.7	0.93		0.9	0.01	0.73	0.96	0.84	-0.63	-0.81	-0.71	-0.91	-0.28	0.68	-0.92	-0.18	0.82	-0.87	-0.94	-0.99
Free Cash Flow Per Share	0.92	0.69	0.9	-0.64	0.84	1.0	-0.6	0.69	0.9		-0.13	0.79	0.95	0.69	-0.7	-0.84	-0.54	-1.0	0.0	0.47	-0.99	0.13	0.53	-0.59	-0.98	-0.92
Roic	0.05	0.26	0.19	0.51	0.04	-0.11	0.4	0.26	0.01	-0.13		-0.65	-0.18	-0.37	-0.14	0.38	0.55	0.14	-0.9	-0.39	0.15	0.38	-0.09	-0.35	0.2	0.12
Inventory Turnover	0.71	0.48	0.51	-0.87	0.64	0.78	-0.68	0.48	0.73	0.79	-0.65		0.86	0.88	-0.44	-0.85	-0.83	-0.8	0.43	0.64	-0.81	-0.35	0.63	-0.36	-0.86	-0.82
Net Income Per Share	0.96	0.81	0.8	-0.8	0.81	0.94	-0.7	0.81	0.96	0.95	-0.18	0.86		0.87	-0.6	-0.89	-0.73	-0.96	-0.06	0.6	-0.96	-0.17	0.76	-0.72	-0.98	-0.99
Days Of Inventory On Hand	0.8	0.76	0.48	-0.94	0.59	0.68	-0.73	0.76	0.84	0.69	-0.37	0.88	0.87		-0.36	-0.8	-0.92	-0.72	0.05	0.72	-0.74	-0.62	0.91	-0.68	-0.8	-0.89
Payables Turnover	-0.67	-0.46	-0.84	0.23	-0.78	-0.7	0.05	-0.46	-0.63	-0.7	-0.14	-0.44	-0.6	-0.36		0.34	0.15	0.73	0.12	-0.24	0.73	-0.37	-0.22	0.39	0.69	0.61
Capex To Revenue	-0.8	-0.65	-0.62	0.82	-0.63	-0.82	0.73	-0.65	-0.81	-0.84	0.38	-0.85	-0.89	-0.8	0.34		0.74	0.84	-0.12	-0.6	0.85	0.23	-0.69	0.56	0.87	0.86
Cash Per Share	-0.65	-0.64	-0.32	0.99	-0.28	-0.5	0.87	-0.64	-0.71	-0.54	0.55	-0.83	-0.73	-0.92	0.15	0.74		0.56	-0.16	-0.89	0.59	0.7	-0.87	0.58	0.66	0.76
Pocfratio	-0.93	-0.71	-0.91	0.66	-0.85	-0.99	0.59	-0.71	-0.91	-1.0	0.14	-0.8	-0.96	-0.72	0.73	0.84	0.56		0.01	-0.51	1.0	-0.1	-0.56	0.61	0.99	0.93
Interest Coverage	-0.3	-0.58	-0.29	-0.13	-0.05	-0.01	-0.03	-0.58	-0.28	0.0	-0.9	0.43	-0.06	0.05	0.12	-0.12	-0.16	0.01		0.0	0.02	-0.07	-0.3	0.67	-0.01	0.15
Capex To Operating Cash Flow	0.64	0.64	0.43	-0.88	0.09	0.42	-0.87	0.64	0.68	0.47	-0.39	0.64	0.6	0.72	-0.24	-0.6	-0.89	-0.51	0.0		-0.53	-0.48	0.77	-0.62	-0.57	-0.68
Pfcf Ratio	-0.94	-0.73	-0.9	0.69	-0.84	-0.99	0.61	-0.73	-0.92	-0.99	0.15	-0.81	-0.96	-0.74	0.73	0.85	0.59	1.0	0.02	-0.53		-0.07	-0.59	0.62	0.99	0.94
Days Payables Outstanding	-0.09	-0.29	0.35	0.61	0.14	0.15	0.42	-0.29	-0.18	0.13	0.38	-0.35	-0.17	-0.62	-0.37	0.23	0.7	-0.1	-0.07	-0.48	-0.07		-0.68	0.3	0.03	0.23
Income Quality	0.78	0.88	0.43	-0.88	0.39	0.51	-0.74	0.88	0.82	0.53	-0.09	0.63	0.76	0.91	-0.22	-0.69	-0.87	-0.56	-0.3	0.77	-0.59	-0.68		-0.87	-0.65	-0.83
Roe	-0.85	-0.99	-0.66	0.63	-0.44	-0.57	0.62	-0.99	-0.87	-0.59	-0.35	-0.36	-0.72	-0.68	0.39	0.56	0.58	0.61	0.67	-0.62	0.62	0.3	-0.87		0.64	0.8
Ev To Operating Cash Flow	-0.94	-0.74	-0.87	0.75	-0.83	-0.98	0.65	-0.74	-0.94	-0.98	0.2	-0.86	-0.98	-0.8	0.69	0.87	0.66	0.99	-0.01	-0.57	0.99	0.03	-0.65	0.64		0.96
Pe Ratio	-0.98	-0.88	-0.81	0.83	-0.76	-0.9	0.72	-0.88	-0.99	-0.92	0.12	-0.82	-0.99	-0.89	0.61	0.86	0.76	0.93	0.15	-0.68	0.94	0.23	-0.83	0.8	0.96

Click cells to compare fundamentals

Caribou Biosciences Account Relationship Matchups

Caribou Biosciences fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	79.18	94.75	27.57	12.27	14.37	13.65
Ptb Ratio	(41.76)	2.34	1.27	1.15	0.57	0.54
Days Sales Outstanding	152.37	308.95	122.91	40.85	76.44	72.62
Book Value Per Share	(0.39)	6.44	4.95	4.99	2.8	2.52
Free Cash Flow Yield	(0.0353)	(0.0392)	(0.26)	(0.25)	(1.0)	(0.95)
Operating Cash Flow Per Share	(0.55)	(0.54)	(1.5)	(1.26)	(1.53)	(1.61)
Stock Based Compensation To Revenue	0.0811	0.36	0.85	0.4	1.67	1.76
Capex To Depreciation	1.46	3.17	4.35	3.29	1.24	1.96
Pb Ratio	(41.76)	2.34	1.27	1.15	0.57	0.54
Ev To Sales	78.02	69.72	25.36	11.57	15.39	14.62
Free Cash Flow Per Share	(0.58)	(0.59)	(1.61)	(1.42)	(1.58)	(1.66)
Roic	(1.41)	(0.16)	(0.31)	(0.29)	(0.59)	(0.62)
Net Income Per Share	(0.57)	(1.11)	(1.64)	(1.38)	(1.65)	(1.73)
Payables Turnover	13.24	0.25	3.18	35.92	32.33	33.95
Sales General And Administrative To Revenue	1.14	2.53	2.74	1.12	4.65	4.88
Research And Ddevelopement To Revenue	2.78	5.44	5.94	3.25	13.02	13.67
Capex To Revenue	0.11	0.33	0.51	0.34	0.49	0.26
Cash Per Share	0.27	6.24	4.07	4.46	2.32	2.42
Pocfratio	(29.47)	(27.96)	(4.2)	(4.53)	(1.04)	(1.09)
Capex To Operating Cash Flow	(0.0396)	(0.096)	(0.0775)	(0.12)	(0.0353)	(0.0371)
Pfcf Ratio	(28.34)	(25.52)	(3.9)	(4.03)	(1.0)	(1.05)
Days Payables Outstanding	27.58	1.5K	114.88	10.16	9.14	8.69
Roe	1.46	(0.17)	(0.33)	(0.28)	(0.59)	(0.62)
Ev To Operating Cash Flow	(29.03)	(20.58)	(3.86)	(4.28)	(1.11)	(1.17)
Pe Ratio	(28.53)	(13.59)	(3.84)	(4.14)	(0.96)	(1.01)
Return On Tangible Assets	(0.89)	(0.15)	(0.26)	(0.24)	(0.48)	(0.5)
Ev To Free Cash Flow	(27.93)	(18.78)	(3.58)	(3.8)	(1.07)	(1.13)
Earnings Yield	(0.0351)	(0.0736)	(0.26)	(0.24)	(1.04)	(0.99)
Net Debt To E B I T D A	0.41	3.64	0.29	0.21	(0.0612)	(0.0581)
Current Ratio	1.96	15.15	9.25	11.97	7.16	6.82
Tangible Book Value Per Share	(0.35)	6.48	5.12	4.99	2.8	2.56
Receivables Turnover	2.4	1.18	2.97	8.93	4.77	2.9
Shareholders Equity Per Share	(0.39)	6.44	4.95	4.99	2.8	2.52
Debt To Equity	(0.0673)	6.68E-4	0.0922	0.0736	0.1	0.11
Capex Per Share	0.0219	0.0518	0.12	0.16	0.054	0.0554

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

Caribou Historical Financial Ratios

About Caribou Financial Ratios Analysis

Caribou Biosciences Financial Ratios Chart

Price To Sales Ratio

Ev To Sales

Payables Turnover

Caribou Biosciences fundamentals Correlations

Caribou Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Caribou Biosciences fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Caribou Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Cash Per Share	+ 0.99	Book Value Per Share
Ev To Operating Cash Flow	+ 0.99	Pocfratio

Pocfratio	- 1.0	Free Cash Flow Per Share
Pe Ratio	- 0.99	Net Income Per Share
Pfcf Ratio	- 0.99	Free Cash Flow Per Share
Pe Ratio	- 0.99	Ev To Sales
Roe	- 0.99	Pb Ratio
Pfcf Ratio	- 0.99	Operating Cash Flow Per Share